| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/16/2000 | US6063802 Ondansetron freeze-dried dosage form compositions for oral administration |
| 05/16/2000 | US6063776 Anticholesterol agents |
| 05/16/2000 | US6063762 Cyclosporin microemulsion with oils, solvents and surfactants |
| 05/16/2000 | US6063761 Hepatoselective pharmaceutical actives |
| 05/16/2000 | US6063759 Conjugate of biologically active compound and polar lipid conjugated to a microparticle for biological targeting |
| 05/16/2000 | US6063405 Sustained release delivery system |
| 05/16/2000 | US6063404 Bioadhesive tablet |
| 05/16/2000 | US6063403 Compressed dry-granulation desogestrel tablets |
| 05/16/2000 | US6063402 Purified galactomannan as an improved pharmaceutical excipient |
| 05/16/2000 | US6063401 Plantago major and hypericum perforatum compound for use in treating a tobacco or nicotine habit |
| 05/16/2000 | US6063400 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 05/16/2000 | US6063399 Blend of (meth)acrylate copolymer and plasticizer |
| 05/16/2000 | US6063398 Cosmetic or dermopharmaceutical patch containing, in an anhydrous polymeric matrix, at least one active compound which is, in particular, unstable in oxidizing mediums, and at least one water-absorbing agent |
| 05/16/2000 | US6063397 Disposable cleansing products for hair and skin |
| 05/16/2000 | US6063395 Sustained rlease |
| 05/16/2000 | US6063394 Injection formulations of avermectins and milbemycins based on castor oil |
| 05/16/2000 | US6063388 Mixture of parahydroxybenzoate, n-(3-chloroallyl)hexammonium chloride and sodium benzoate |
| 05/16/2000 | US6063383 Pharmaceutical suppository composites for fever and influenza and method of producing the composites |
| 05/16/2000 | US6063363 Treatment for upper respiratory tract infections with potassium salts |
| 05/16/2000 | US6063313 Blending and extrusion of drugs, spheronizing and drying |
| 05/16/2000 | US6063194 Dry powder deposition apparatus |
| 05/16/2000 | US6063138 Method and apparatus for the formation of particles |
| 05/16/2000 | US6063116 Modulation of cell proliferation and wound healing |
| 05/16/2000 | US6063061 Fragmented polymeric compositions and methods for their use |
| 05/16/2000 | CA2173403C External therapeutic composition for dermatitis |
| 05/16/2000 | CA2116115C Sustained-release matrices for dental application |
| 05/16/2000 | CA2098893C Antioxidant composition of natural products and method of production thereof |
| 05/16/2000 | CA2044548C Coating process by a ph-sensitive polymer of active ingredients |
| 05/16/2000 | CA2006778C Nifedipine pharmaceutical preparation |
| 05/16/2000 | CA1340994C Treatment of conditions and disease |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026207A1 Products for body hygiene based on lapacho extracts containing quercitine, their preparation and use |
| 05/11/2000 | WO2000025908A1 Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating |
| 05/11/2000 | WO2000025841A1 Implant with cavities containing therapeutic agents |
| 05/11/2000 | WO2000025829A2 Radiodense compositions |
| 05/11/2000 | WO2000025826A1 Lactone bearing absorbable polymers |
| 05/11/2000 | WO2000025824A2 Stable preparations with hyperforin |
| 05/11/2000 | WO2000025823A1 Muco-adhesive polymers, use thereof and method for producing the same |
| 05/11/2000 | WO2000025822A1 Transdermal delivery of medications using a combination of penetration enhancers |
| 05/11/2000 | WO2000025819A1 Enhanced radiation therapy |
| 05/11/2000 | WO2000025802A1 Pharmaceutical composition having antitumor activity and process for the preparation thereof |
| 05/11/2000 | WO2000025792A1 Estradiol-containing adhesive preparation |
| 05/11/2000 | WO2000025790A1 Controlled delivery of antidepressants |
| 05/11/2000 | WO2000025785A1 Plastics container containing stabilised drug formulations |
| 05/11/2000 | WO2000025783A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder |
| 05/11/2000 | WO2000025775A1 Water-miscible pharmaceutical compositions of paclitaxel |
| 05/11/2000 | WO2000025772A1 Compositions of and process for producing isotretinoin having low particle size |
| 05/11/2000 | WO2000025762A1 Device for a transdermal and phonophoretic combination therapy and the use thereof in a method for medical application |
| 05/11/2000 | WO2000025761A1 Capsules with porous mineral cortex |
| 05/11/2000 | WO2000025760A1 Process for producing hard capsule |
| 05/11/2000 | WO2000025759A1 Orally applicable therapeutic dosage form which spontaneously disintegrates upon contact with a liquid and method for producing the same |
| 05/11/2000 | WO2000025758A1 Oral administration of adenosine analogs |
| 05/11/2000 | WO2000025757A1 Sustained release delivery of highly water-soluble compounds |
| 05/11/2000 | WO2000025756A2 Medicament for topical treatment of inflammatory intestinal diseases |
| 05/11/2000 | WO2000025755A1 Dosage forms containing taste masked active agents |
| 05/11/2000 | WO2000025754A2 Solid oral dosage forms containing alginic acid and famotidine |
| 05/11/2000 | WO2000025753A2 Controlled delivery of active agents |
| 05/11/2000 | WO2000025752A1 Multiparticulate modified release composition |
| 05/11/2000 | WO2000025751A2 Improved amoxycillin and clavulanate composition |
| 05/11/2000 | WO2000025750A1 Controlled-release formulations of metamizole |
| 05/11/2000 | WO2000025749A1 Use of xanthan gums for preparing pharmaceutical compositions |
| 05/11/2000 | WO2000025748A1 Liposomes |
| 05/11/2000 | WO2000025747A1 Liposome with lowered toxicity |
| 05/11/2000 | WO2000025746A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
| 05/11/2000 | WO2000025745A2 Irrigation solution and method for inhibition of pain and inflammation |
| 05/11/2000 | WO2000025744A1 Granular, free-flowing pharmaceutical composition, and straw-like dosage form for oral administration thereof |
| 05/11/2000 | WO2000025743A2 Improved growth stimulant compositions |
| 05/11/2000 | WO2000025742A1 Expandable gastroretentive therapeutical system with prolonged stomach retention time |
| 05/11/2000 | WO2000025723A2 Methods and compositions for the prevention of tolerance to medications |
| 05/11/2000 | WO2000025671A1 Manganese compositions and methods for mri |
| 05/11/2000 | WO2000025612A1 Smoking products containing antioxidants |
| 05/11/2000 | WO2000025606A1 Solid delivery systems for aroma ingredients |
| 05/11/2000 | WO2000025602A2 Use of calcareous material for foodstuff and cosmetic material |
| 05/11/2000 | WO2000025568A1 Gellan gum seed coating |
| 05/11/2000 | WO2000011968A8 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID |
| 05/11/2000 | WO2000008043A3 Prevention and treatment of viral disease |
| 05/11/2000 | WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 05/11/2000 | WO2000007572A3 Two-piece capsule for receiving pharmaceutical preparations for powder inhalers |
| 05/11/2000 | WO2000007571A3 Formulations having probiotically active microorganisms |
| 05/11/2000 | WO2000007565A3 Methods of ophthalmic administration |
| 05/11/2000 | WO2000006124A3 A novel excipient for the lyophilization of aqueous suspensions of microparticles |
| 05/11/2000 | DE19910188A1 Implant, especially a stent, comprises a support at least partly covered with a layer of metal oxide and/or ceramic material to inhibit excessive cell growth |
| 05/11/2000 | DE19903570A1 Stabile Zubereitungen mit Hyperforin Stable preparations with hyperforin |
| 05/11/2000 | DE19855421A1 Implant, especially a stent, having surface cavities containing a radioactive material to inhibit excessive cell growth |
| 05/11/2000 | DE19851617A1 Treatment of infant and adult respiratory distress syndrome comprises bronchoalveolar lavage with a dilute lung surfactant solution followed by administration of a lung surfactant |
| 05/11/2000 | DE19851282A1 Zusammensetzung einer pharmazeutisch wirksamen Substanz, appliziert in einem spezifischen Delivery-System zur Prävention und Behandlung von Infektions-Krankheiten Composition of a pharmaceutically active substance, applied in a specific delivery system for the prevention and treatment of infectious diseases |
| 05/11/2000 | DE19850790A1 Use of nicotine patch for treating Parkinson's disease |
| 05/11/2000 | CA2653839A1 Multiparticulate modified release composition |
| 05/11/2000 | CA2349674A1 Capsules with porous mineral cortex |
| 05/11/2000 | CA2349346A1 Lactone bearing absorbable polymers |
| 05/11/2000 | CA2349241A1 Smoking products containing antioxidants |
| 05/11/2000 | CA2349158A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | CA2348536A1 Radiodense compositions |
| 05/11/2000 | CA2348499A1 Use of calcareous material for foodstuff and cosmetic material |
| 05/11/2000 | CA2347915A1 Enhanced radiation therapy |
| 05/11/2000 | CA2347855A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder |
| 05/11/2000 | CA2347098A1 Compositions of and process for producing isotretinoin having low particle size |
| 05/11/2000 | CA2346897A1 Solid delivery systems for aroma ingredients |
| 05/11/2000 | CA2346857A1 Implant with cavities containing therapeutic agents |
| 05/11/2000 | CA2345697A1 Water-miscible pharmaceutical compositions of paclitaxel |